Bayesian vs Frequentist A/B Testing
Compare Bayesian and frequentist A/B testing by assumptions, uncertainty, stopping rules, and decision costs rather than universal speed or accuracy claims.
- Can express modeled probabilities about effect size and decision loss
- Can incorporate relevant prior information transparently
- Supports decisions based on posterior expected utility
- Represents uncertainty across a range of plausible effects
- Provides long-run error guarantees when the planned design and assumptions hold
- Supports pre-registration and reproducible analysis plans
- Offers fixed-horizon and sequential designs
- Makes multiplicity and stopping rules explicit
- Conclusions depend on the likelihood, prior, and decision rule
- Poorly justified priors or model choices can distort the result
- Optional stopping is not automatically harmless under every model or objective
- Different platform implementations may not be directly comparable
- P-values and confidence intervals are often misinterpreted
- Unplanned peeking or metric selection can invalidate nominal error rates
- A significance threshold does not measure business value
- A fixed-horizon design can be inflexible when the decision context changes
Use the framework whose assumptions and decision rule your team can defend. A planned frequentist sequential design can support repeated looks; a Bayesian analysis can support direct probability statements conditional on its model and prior. Neither label removes the need to define practical value, uncertainty, and the cost of a wrong decision.— Atticus Li
Start With the Question, Not the Camp
Frequentist and Bayesian analyses are not interchangeable scoreboards. They condition on different things and justify different statements.
A frequentist p-value asks how unusual the observed data, or more extreme data, would be under a specified null model. It does not report the probability that the null hypothesis is true or the probability that a result is a false positive. A frequentist confidence interval comes from a procedure designed to cover the true parameter at a stated rate over repeated samples; a realized interval is not automatically a probability distribution over the parameter.
A Bayesian analysis combines a likelihood and prior to produce a posterior distribution. A credible interval can support a probability statement about the parameter conditional on that model, prior, and observed data. That statement is only as useful as those assumptions.
Stopping Rules Are Part of the Method
"Bayesian means you can peek" and "frequentist means you must never peek" are both too broad.
Frequentist group-sequential, alpha-spending, and always-valid methods can support repeated examination when planned and implemented correctly. Unplanned stopping based on an ordinary fixed-horizon p-value can break its advertised error control.
Bayesian updating is mathematically coherent as data arrive, but a production decision policy still needs a stopping rule, a loss function, and checks for model misspecification. Optional stopping can affect calibration, resource use, and repeated-decision behavior depending on the objective.
Compare Operating Characteristics
Before choosing a method, simulate or otherwise evaluate the actual policy:
- What effects are plausible?
- What is the smallest effect worth acting on?
- What are the costs of shipping, waiting, and missing an improvement?
- How often will the team review results?
- How are multiple variants, metrics, and segments handled?
- What happens when the interval includes both meaningful harm and meaningful benefit?
Those questions determine decision quality more than the statistical label.
A Practical Governance Pattern
Write an analysis plan before exposure begins. State the primary metric, estimand, assignment unit, interference assumptions, missing-data policy, stopping rule, and decision rule. For a Bayesian analysis, add the likelihood, prior, sensitivity checks, and utility or loss model. For a frequentist analysis, add the error rate, power or precision target, multiplicity plan, and whether the design is fixed or sequential.
Report the estimated effect with an interval and the scale on which it is measured. Then separate the statistical conclusion from the business action. "The data remain compatible with effects from modest harm to useful benefit" is often more honest and actionable than a binary winner label.